Il-1 receptor based antagonists and methods of making and using
CA 2502385 C · Owner: Stahl, Neil · Inventors: Stahl, Neil; Yancopoulos, George D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a fusion polypeptide capable of binding interleukin -1 (IL-1) to form a nonfunctional complex. It also provides a nucleic acid sequence encoding the fusion polypeptide and methods of making and uses for the fusion polypeptide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2003 and granted June 12, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.